{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,11]],"date-time":"2025-06-11T04:13:02Z","timestamp":1749615182104,"version":"3.41.0"},"reference-count":61,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,6,10]],"date-time":"2025-06-10T00:00:00Z","timestamp":1749513600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,6,10]],"date-time":"2025-06-10T00:00:00Z","timestamp":1749513600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"The Role of HIF-1\u03b1-Mediated PFKFB3 Upregulation and MMP Activation in Lenvatinib Resistance in Hepatocellular Carcinoma","award":["2023LYYYGZRP0001"],"award-info":[{"award-number":["2023LYYYGZRP0001"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Discov Onc"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Intrahepatic cholangiocarcinoma is a malignant tumor of hepatobiliary epithelial cells. In recent years, its incidence has gradually increased. It has a very high fatality rate and low survival rate, and the existing predictive factors for intrahepatic cholangiocarcinoma are unclear. The role of anoikis, a form of programmed cell death, in intrahepatic cholangiocarcinoma is not fully understood. This study focuses on identifying and analyzing anoikis-related differentially expressed genes in intrahepatic cholangiocarcinoma, aiming to enhance our understanding of potential treatment strategies and prognosis of intrahepatic cholangiocarcinoma.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>In our study, we employed a clustering algorithm to classify samples from The Cancer Genome Atlas (TCGA) based on differentially expressed overlapping anoikis-related genes. Subsequently, we utilized Weighted Gene Co-expression Network Analysis (WGCNA) to identify highly correlated genes and constructed a prognostic risk model based on univariate Cox proportional hazard regression. We validated the model's reliability using external datasets from the International Cancer Genome Consortium (ICGC) and the Gene Expression Omnibus (GEO). Finally, we used the CIBERSORT algorithm to investigate the correlation between risk scores and immune infiltration.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>The results showed that the TCGA cohort could be divided into 2 subgroups, among which subgroup B had a lower survival probability. We identified three prognostic genes (EGF, BNIP3, TDGF1) associated with anorexia. The prognostic risk model effectively predicted overall survival and was validated in ICGC and GEO data sets. Furthermore, there were significant correlations between infiltrating immune cells and prognostic genes and risk scores.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>We identified subgroups and prognostic genes associated with ICCA dysregulation, which are important for understanding the treatment and prognosis of ICCA.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1007\/s12672-025-02840-5","type":"journal-article","created":{"date-parts":[[2025,6,10]],"date-time":"2025-06-10T18:57:46Z","timestamp":1749581866000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Identification of a novel anoikis-related gene signature to predict prognosis and tumor microenvironment in intrahepatic cholangiocarcinoma carcinoma"],"prefix":"10.1007","volume":"16","author":[{"given":"Xuan","family":"Zhou","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bai","family":"Wei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mingjie","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiangru","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuting","family":"Duan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,6,10]]},"reference":[{"issue":"2","key":"2840_CR1","doi-asserted-by":"publisher","first-page":"198","DOI":"10.3322\/caac.21759","volume":"73","author":"D Moris","year":"2023","unstructured":"Moris D, Palta M, Kim C, et al. Advances in the treatment of intrahepatic cholangiocarcinoma: an overview of the current and future therapeutic landscape forclinicians. CA Cancer J Clin. 2023;73(2):198\u2013222. https:\/\/doi.org\/10.3322\/caac.21759.","journal-title":"CA Cancer J Clin"},{"issue":"5","key":"2840_CR2","doi-asserted-by":"publisher","first-page":"790","DOI":"10.21037\/hbsn-23-411","volume":"12","author":"N Nishida","year":"2023","unstructured":"Nishida N. The role of FGFR inhibitors in the treatment of intrahepatic cholangiocarcinoma\u2014unveiling the future challenges in drug therapy. Hepatobiliary Surg Nutr. 2023;12(5):790\u20134. https:\/\/doi.org\/10.21037\/hbsn-23-411.","journal-title":"Hepatobiliary Surg Nutr"},{"issue":"3","key":"2840_CR3","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1002\/hep4.1142","volume":"2","author":"A Merdrignac","year":"2018","unstructured":"Merdrignac A, Angenard G, Allain C, et al. A novel transforming growth factor beta-induced long noncoding RNA promotes an inflammatory microenvironment in human intrahepatic cholangiocarcinoma. Hepatol Commun. 2018;2(3):254\u201369. https:\/\/doi.org\/10.1002\/hep4.1142.","journal-title":"Hepatol Commun"},{"issue":"5","key":"2840_CR4","doi-asserted-by":"publisher","first-page":"1068","DOI":"10.1016\/j.ajpath.2017.01.013","volume":"187","author":"M\u00c1 Manzanares","year":"2017","unstructured":"Manzanares M\u00c1, Usui A, Campbell DJ, et al. Transforming growth factors \u03b1 and \u03b2 are essential for modeling cholangiocarcinoma desmoplasia and progression in a three-dimensional organotypic culture model. Am J Pathol. 2017;187(5):1068\u201392. https:\/\/doi.org\/10.1016\/j.ajpath.2017.01.013.","journal-title":"Am J Pathol"},{"issue":"3","key":"2840_CR5","doi-asserted-by":"publisher","first-page":"1042","DOI":"10.1002\/hep.26384","volume":"58","author":"M Cadamuro","year":"2013","unstructured":"Cadamuro M, Nardo G, Indraccolo S, et al. Platelet-derived growth factor-D and Rho GTPases regulate recruitment of cancer-associated fibroblasts in cholangiocarcinoma. Hepatology. 2013;58(3):1042\u201353. https:\/\/doi.org\/10.1002\/hep.26384.","journal-title":"Hepatology"},{"issue":"33","key":"2840_CR6","doi-asserted-by":"publisher","first-page":"22835","DOI":"10.1074\/jbc.M114.563064","volume":"289","author":"S Rizvi","year":"2014","unstructured":"Rizvi S, Mertens JC, Bronk SF, et al. Platelet-derived growth factor primes cancer-associated fibroblasts for apoptosis. J Biol Chem. 2014;289(33):22835\u201349. https:\/\/doi.org\/10.1074\/jbc.M114.563064.","journal-title":"J Biol Chem"},{"key":"2840_CR7","unstructured":"Serum extracellular vesicles contain protein biomarkers for primary sclerosing cholangitis and cholangiocarcinoma. [2024-03-05]. https:\/\/pubmed.ncbi.nlm.nih.gov\/28555885\/"},{"issue":"21","key":"2840_CR8","doi-asserted-by":"publisher","first-page":"3689","DOI":"10.3390\/cancers16213689","volume":"16","author":"TK Sahin","year":"2024","unstructured":"Sahin TK, Ayasun R, Rizzo A, et al. Prognostic value of neutrophil-to-eosinophil ratio (NER) in cancer: a systematic review and meta-analysis. Cancers. 2024;16(21):3689. https:\/\/doi.org\/10.3390\/cancers16213689.","journal-title":"Cancers"},{"issue":"2","key":"2840_CR9","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1002\/path.3000","volume":"226","author":"ML Taddei","year":"2012","unstructured":"Taddei ML, Giannoni E, Fiaschi T, et al. Anoikis: an emerging hallmark in health and diseases. J Pathol. 2012;226(2):380\u201393. https:\/\/doi.org\/10.1002\/path.3000.","journal-title":"J Pathol"},{"issue":"11\u201312","key":"2840_CR10","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1007\/s10495-019-01573-5","volume":"24","author":"D Guha","year":"2019","unstructured":"Guha D, Saha T, Bose S, et al. Integrin-EGFR interaction regulates anoikis resistance in colon cancer cells. Apoptosis Int J Program Cell Death. 2019;24(11\u201312):958\u201371. https:\/\/doi.org\/10.1007\/s10495-019-01573-5.","journal-title":"Apoptosis Int J Program Cell Death"},{"issue":"38","key":"2840_CR11","doi-asserted-by":"publisher","first-page":"5764","DOI":"10.1038\/s41388-021-01988-y","volume":"40","author":"S Du","year":"2021","unstructured":"Du S, Yang Z, Lu X, et al. Anoikis resistant gastric cancer cells promote angiogenesis and peritoneal metastasis through C\/EBP\u03b2-mediated PDGFB autocrine and paracrine signaling. Oncogene. 2021;40(38):5764\u201379. https:\/\/doi.org\/10.1038\/s41388-021-01988-y.","journal-title":"Oncogene"},{"issue":"1","key":"2840_CR12","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1186\/s13058-018-1030-y","volume":"20","author":"H Zhang","year":"2018","unstructured":"Zhang H, Fredericks T, Xiong G, et al. Membrane associated collagen XIII promotes cancer metastasis and enhances anoikis resistance. Breast Cancer Res. 2018;20(1):116. https:\/\/doi.org\/10.1186\/s13058-018-1030-y.","journal-title":"Breast Cancer Res"},{"issue":"5","key":"2840_CR13","doi-asserted-by":"publisher","first-page":"1406","DOI":"10.7150\/jca.47032","volume":"12","author":"H Wang","year":"2021","unstructured":"Wang H, Ren R, Yang Z, et al. The COL11A1\/Akt\/CREB signaling axis enables mitochondrial-mediated apoptotic evasion to promote chemoresistance in pancreatic cancer cells through modulating BAX\/BCL-2 function. J Cancer. 2021;12(5):1406\u201320. https:\/\/doi.org\/10.7150\/jca.47032.","journal-title":"J Cancer"},{"issue":"35","key":"2840_CR14","doi-asserted-by":"publisher","first-page":"3766","DOI":"10.1038\/onc.2011.89","volume":"30","author":"JV Burnier","year":"2011","unstructured":"Burnier JV, Wang N, Michel RP, et al. Type IV collagen-initiated signals provide survival and growth cues required for liver metastasis. Oncogene. 2011;30(35):3766\u201383. https:\/\/doi.org\/10.1038\/onc.2011.89.","journal-title":"Oncogene"},{"issue":"12","key":"2840_CR15","doi-asserted-by":"publisher","first-page":"1455","DOI":"10.1080\/17425255.2021.2029405","volume":"17","author":"A Rizzo","year":"2021","unstructured":"Rizzo A, Santoni M, Mollica V, et al. Peripheral neuropathy and headache in cancer patients treated with immunotherapy and immuno-oncology combinations: the MOUSEION-02 study. Expert Opin Drug Metab Toxicol. 2021;17(12):1455\u201366. https:\/\/doi.org\/10.1080\/17425255.2021.2029405.","journal-title":"Expert Opin Drug Metab Toxicol"},{"issue":"12","key":"2840_CR16","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1007\/s00520-023-08083-w","volume":"31","author":"DC Guven","year":"2023","unstructured":"Guven DC, Erul E, Kaygusuz Y, et al. Immune checkpoint inhibitor-related hearing loss: a systematic review and analysis of individual patient data. Support Care Cancer. 2023;31(12):624. https:\/\/doi.org\/10.1007\/s00520-023-08083-w.","journal-title":"Support Care Cancer"},{"issue":"16","key":"2840_CR17","doi-asserted-by":"publisher","first-page":"4678","DOI":"10.7150\/thno.36276","volume":"9","author":"JC Lu","year":"2019","unstructured":"Lu JC, Zeng HY, Sun QM, et al. Distinct PD-L1\/PD1 profiles and clinical implications in intrahepatic cholangiocarcinoma patients with different risk factors. Theranostics. 2019;9(16):4678\u201387. https:\/\/doi.org\/10.7150\/thno.36276.","journal-title":"Theranostics"},{"key":"2840_CR18","unstructured":"Second-line Treatment in Advanced Biliary Tract Cancer: Today and Tomorrow. [2025-01-16]. https:\/\/pubmed.ncbi.nlm.nih.gov\/32487595\/"},{"issue":"5","key":"2840_CR19","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1080\/17474124.2021.1864325","volume":"15","author":"A Rizzo","year":"2021","unstructured":"Rizzo A, Brandi G. BILCAP trial and adjuvant capecitabine in resectable biliary tract cancer: reflections on a standard of care. Expert Rev Gastroenterol Hepatol. 2021;15(5):483\u20135. https:\/\/doi.org\/10.1080\/17474124.2021.1864325.","journal-title":"Expert Rev Gastroenterol Hepatol"},{"key":"2840_CR20","doi-asserted-by":"publisher","first-page":"1055304","DOI":"10.3389\/fimmu.2022.1055304","volume":"13","author":"YY Zhang","year":"2022","unstructured":"Zhang YY, Li XW, Li XD, et al. Comprehensive analysis of anoikis-related long non-coding RNA immune infiltration in patients with bladder cancer and immunotherapy. Front Immunol. 2022;13:1055304. https:\/\/doi.org\/10.3389\/fimmu.2022.1055304.","journal-title":"Front Immunol"},{"issue":"1","key":"2840_CR21","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1186\/s40537-023-00803-7","volume":"10","author":"Z Zheng","year":"2023","unstructured":"Zheng Z, Yang H, Shi Y, et al. Identification of tumor antigens and anoikis-based molecular subtypes in the hepatocellular carcinoma immune microenvironment: implications for mRNA vaccine development and precision treatment. J Big Data. 2023;10(1):129. https:\/\/doi.org\/10.1186\/s40537-023-00803-7.","journal-title":"J Big Data"},{"key":"2840_CR22","doi-asserted-by":"publisher","first-page":"1122570","DOI":"10.3389\/fimmu.2023.1122570","volume":"14","author":"Y Dong","year":"2023","unstructured":"Dong Y, Xu C, Su G, et al. Clinical value of anoikis-related genes and molecular subtypes identification in bladder urothelial carcinoma and in vitro validation. Front Immunol. 2023;14:1122570. https:\/\/doi.org\/10.3389\/fimmu.2023.1122570.","journal-title":"Front Immunol"},{"issue":"1","key":"2840_CR23","doi-asserted-by":"publisher","first-page":"1642","DOI":"10.1038\/s41467-022-29164-0","volume":"13","author":"G Song","year":"2022","unstructured":"Song G, Shi Y, Meng L, et al. Single-cell transcriptomic analysis suggests two molecularly subtypes of intrahepatic cholangiocarcinoma. Nat Commun. 2022;13(1):1642. https:\/\/doi.org\/10.1038\/s41467-022-29164-0.","journal-title":"Nat Commun"},{"key":"2840_CR24","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.937957","volume":"12","author":"GM Mranda","year":"2022","unstructured":"Mranda GM, Xiang ZP, Liu JJ, et al. Advances in prognostic and therapeutic targets for hepatocellular carcinoma and intrahepatic cholangiocarcinoma: the hippo signaling pathway. Front Oncol. 2022;12: 937957. https:\/\/doi.org\/10.3389\/fonc.2022.937957.","journal-title":"Front Oncol"},{"issue":"6","key":"2840_CR25","first-page":"1654","volume":"62","author":"X Guo","year":"2002","unstructured":"Guo X, Knudsen BS, Peehl DM, et al. Retinol metabolism and lecithin:retinol acyltransferase levels are reduced in cultured human prostate cancer cells and tissue specimens. Can Res. 2002;62(6):1654\u201361.","journal-title":"Can Res"},{"issue":"5","key":"2840_CR26","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1158\/1055-9965.EPI-13-0017","volume":"22","author":"SJ Hendrickson","year":"2013","unstructured":"Hendrickson SJ, Lindstr\u00f6m S, Eliassen AH, et al. Plasma carotenoid- and retinol-weighted multi-SNP scores and risk of breast cancer in the National Cancer Institute Breast and Prostate Cancer Cohort Consortium. Cancer Epidemiol Biomark Prevent. 2013;22(5):927\u201336. https:\/\/doi.org\/10.1158\/1055-9965.EPI-13-0017.","journal-title":"Cancer Epidemiol Biomark Prevent"},{"issue":"3","key":"2840_CR27","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1007\/s12029-010-9130-7","volume":"41","author":"PY Fong","year":"2010","unstructured":"Fong PY, Fesinmeyer MD, White E, et al. Association of diabetes susceptibility gene calpain-10 with pancreatic cancer among smokers. J Gastrointest Cancer. 2010;41(3):203\u20138. https:\/\/doi.org\/10.1007\/s12029-010-9130-7.","journal-title":"J Gastrointest Cancer"},{"issue":"1","key":"2840_CR28","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.ejcb.2016.11.004","volume":"96","author":"B Kalbe","year":"2017","unstructured":"Kalbe B, Schulz VM, Schlimm M, et al. Helional-induced activation of human olfactory receptor 2J3 promotes apoptosis and inhibits proliferation in a non-small-cell lung cancer cell line. Eur J Cell Biol. 2017;96(1):34\u201346. https:\/\/doi.org\/10.1016\/j.ejcb.2016.11.004.","journal-title":"Eur J Cell Biol"},{"issue":"3","key":"2840_CR29","doi-asserted-by":"publisher","first-page":"4330","DOI":"10.18632\/oncotarget.13836","volume":"8","author":"G Sanz","year":"2017","unstructured":"Sanz G, Leray I, Gr\u00e9bert D, et al. Structurally related odorant ligands of the olfactory receptor OR51E2 differentially promote metastasis emergence and tumor growth. Oncotarget. 2017;8(3):4330\u201341. https:\/\/doi.org\/10.18632\/oncotarget.13836.","journal-title":"Oncotarget"},{"issue":"30","key":"2840_CR30","doi-asserted-by":"publisher","first-page":"48231","DOI":"10.18632\/oncotarget.10197","volume":"7","author":"D Massberg","year":"2016","unstructured":"Massberg D, Jovancevic N, Offermann A, et al. The activation of OR51E1 causes growth suppression of human prostate cancer cells. Oncotarget. 2016;7(30):48231\u201349. https:\/\/doi.org\/10.18632\/oncotarget.10197.","journal-title":"Oncotarget"},{"issue":"31","key":"2840_CR31","doi-asserted-by":"publisher","first-page":"4071","DOI":"10.3748\/wjg.v18.i31.4071","volume":"18","author":"H Nakagawa","year":"2012","unstructured":"Nakagawa H, Maeda S. Inflammation- and stress-related signaling pathways in hepatocarcinogenesis. World J Gastroenterol. 2012;18(31):4071\u201381. https:\/\/doi.org\/10.3748\/wjg.v18.i31.4071.","journal-title":"World J Gastroenterol"},{"key":"2840_CR32","unstructured":"Dissecting the mechanisms of immune checkpoint. [2024-06-19]. https:\/\/pubmed.ncbi.nlm.nih.gov\/31925406\/"},{"issue":"7","key":"2840_CR33","doi-asserted-by":"publisher","first-page":"928","DOI":"10.1016\/j.ccell.2021.04.004","volume":"39","author":"M Hornburg","year":"2021","unstructured":"Hornburg M, Desbois M, Lu S, et al. Single-cell dissection of cellular components and interactions shaping the tumor immune phenotypes in ovarian cancer. Cancer Cell. 2021;39(7):928-944.e6. https:\/\/doi.org\/10.1016\/j.ccell.2021.04.004.","journal-title":"Cancer Cell"},{"issue":"7950","key":"2840_CR34","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1038\/s41586-022-05628-7","volume":"615","author":"A Gurtner","year":"2023","unstructured":"Gurtner A, Borrelli C, Gonzalez-Perez I, et al. Active eosinophils regulate host defence and immune responses in colitis. Nature. 2023;615(7950):151\u20137. https:\/\/doi.org\/10.1038\/s41586-022-05628-7.","journal-title":"Nature"},{"issue":"1","key":"2840_CR35","doi-asserted-by":"publisher","first-page":"1747","DOI":"10.1038\/s41467-017-01830-8","volume":"8","author":"D Schmid","year":"2017","unstructured":"Schmid D, Park CG, Hartl CA, et al. T cell-targeting nanoparticles focus delivery of immunotherapy to improve antitumor immunity. Nat Commun. 2017;8(1):1747. https:\/\/doi.org\/10.1038\/s41467-017-01830-8.","journal-title":"Nat Commun"},{"issue":"3","key":"2840_CR36","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1038\/s41590-018-0292-y","volume":"20","author":"M Liu","year":"2019","unstructured":"Liu M, O\u2019Connor RS, Trefely S, et al. Metabolic rewiring of macrophages by CpG potentiates clearance of cancer cells and overcomes tumor-expressed CD47-mediated \u201cdon\u2019t-eat-me\u201d signal. Nat Immunol. 2019;20(3):265\u201375. https:\/\/doi.org\/10.1038\/s41590-018-0292-y.","journal-title":"Nat Immunol"},{"issue":"4","key":"2840_CR37","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1038\/nri3174","volume":"12","author":"E Vivier","year":"2012","unstructured":"Vivier E, Ugolini S, Blaise D, et al. Targeting natural killer cells and natural killer T cells in cancer. Nat Rev Immunol. 2012;12(4):239\u201352. https:\/\/doi.org\/10.1038\/nri3174.","journal-title":"Nat Rev Immunol"},{"issue":"9","key":"2840_CR38","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1038\/ni.3518","volume":"17","author":"C Guillerey","year":"2016","unstructured":"Guillerey C, Huntington ND, Smyth MJ. Targeting natural killer cells in cancer immunotherapy. Nat Immunol. 2016;17(9):1025\u201336. https:\/\/doi.org\/10.1038\/ni.3518.","journal-title":"Nat Immunol"},{"issue":"13","key":"2840_CR39","doi-asserted-by":"publisher","first-page":"3744","DOI":"10.1158\/1078-0432.CCR-21-0164","volume":"27","author":"LN Kerbauy","year":"2021","unstructured":"Kerbauy LN, Marin ND, Kaplan M, et al. Combining AFM13, a bispecific CD30\/CD16 antibody, with cytokine-activated blood and cord blood-derived NK cells facilitates CAR-like responses against CD30+ malignancies. Clin Cancer Res. 2021;27(13):3744\u201356. https:\/\/doi.org\/10.1158\/1078-0432.CCR-21-0164.","journal-title":"Clin Cancer Res"},{"issue":"15","key":"2840_CR40","doi-asserted-by":"publisher","first-page":"5134","DOI":"10.1158\/0008-5472.CAN-10-4222","volume":"71","author":"P Hubert","year":"2011","unstructured":"Hubert P, Heitzmann A, Viel S, et al. Antibody-dependent cell cytotoxicity synapses form in mice during tumor-specific antibody immunotherapy. Can Res. 2011;71(15):5134\u201343. https:\/\/doi.org\/10.1158\/0008-5472.CAN-10-4222.","journal-title":"Can Res"},{"issue":"13","key":"2840_CR41","doi-asserted-by":"publisher","first-page":"3946","DOI":"10.1016\/j.celrep.2018.05.082","volume":"23","author":"HL Matlung","year":"2018","unstructured":"Matlung HL, Babes L, Zhao XW, et al. Neutrophils kill antibody-opsonized cancer cells by trogoptosis. Cell Rep. 2018;23(13):3946-3959.e6. https:\/\/doi.org\/10.1016\/j.celrep.2018.05.082.","journal-title":"Cell Rep"},{"issue":"7","key":"2840_CR42","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20201963","volume":"219","author":"M Boieri","year":"2022","unstructured":"Boieri M, Malishkevich A, Guennoun R, et al. CD4+ T helper 2 cells suppress breast cancer by inducing terminal differentiation. J Exp Med. 2022;219(7): e20201963. https:\/\/doi.org\/10.1084\/jem.20201963.","journal-title":"J Exp Med"},{"issue":"7","key":"2840_CR43","doi-asserted-by":"publisher","first-page":"1612","DOI":"10.1016\/j.cell.2020.05.017","volume":"181","author":"DY Oh","year":"2020","unstructured":"Oh DY, Kwek SS, Raju SS, et al. Intratumoral CD4+ T cells mediate anti-tumor cytotoxicity in human bladder cancer. Cell. 2020;181(7):1612-1625.e13. https:\/\/doi.org\/10.1016\/j.cell.2020.05.017.","journal-title":"Cell"},{"issue":"1","key":"2840_CR44","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1186\/s40425-017-0294-6","volume":"5","author":"A Ajina","year":"2017","unstructured":"Ajina A, Maher J. Prospects for combined use of oncolytic viruses and CAR T-cells. J Immunother Cancer. 2017;5(1):90. https:\/\/doi.org\/10.1186\/s40425-017-0294-6.","journal-title":"J Immunother Cancer"},{"issue":"2 Suppl","key":"2840_CR45","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.ijrobp.2003.11.041","volume":"59","author":"RS Herbst","year":"2004","unstructured":"Herbst RS. Review of epidermal growth factor receptor biology. Int J Radiat Oncol Biol Phys. 2004;59(2 Suppl):21\u20136. https:\/\/doi.org\/10.1016\/j.ijrobp.2003.11.041.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"2840_CR46","doi-asserted-by":"publisher","first-page":"14723","DOI":"10.1038\/s41598-023-41139-9","volume":"13","author":"Z Zhong","year":"2023","unstructured":"Zhong Z, Xie F, Yin J, et al. Development of a prognostic model for anoikis and identifies hub genes in hepatocellular carcinoma. Sci Rep. 2023;13(1):14723. https:\/\/doi.org\/10.1038\/s41598-023-41139-9.","journal-title":"Sci Rep"},{"issue":"4","key":"2840_CR47","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1016\/j.bbrc.2004.12.193","volume":"328","author":"V Pag\u00e9","year":"2005","unstructured":"Pag\u00e9 V, C\u00f4t\u00e9 M, Rancourt C, et al. BAG-1 p29 protein prevents drug-induced cell death in the presence of EGF and enhances resistance to anoikis in SKOV3 human ovarian cancer cells. Biochem Biophys Res Commun. 2005;328(4):874\u201384. https:\/\/doi.org\/10.1016\/j.bbrc.2004.12.193.","journal-title":"Biochem Biophys Res Commun"},{"key":"2840_CR48","unstructured":"The 14-3-3\u03c3 protein promotes HCC anoikis resistance by inhibiting EGFR degradation and thereby activating the EGFR-dependent ERK1\/2 signaling pathway. [2025-01-16]. https:\/\/pubmed.ncbi.nlm.nih.gov\/33391517\/"},{"key":"2840_CR49","unstructured":"Development of a prognostic model for anoikis and identifies hub genes in hepatocellular carcinoma. [2025-01-16]. https:\/\/pubmed.ncbi.nlm.nih.gov\/37679418\/"},{"key":"2840_CR50","unstructured":"The histone H3K9 demethylase KDM3A promotes anoikis by transcriptionally activating pro-apoptotic genes BNIP3 and BNIP3L. [2025-01-16]. https:\/\/pubmed.ncbi.nlm.nih.gov\/27472901\/"},{"issue":"18","key":"2840_CR51","first-page":"6669","volume":"61","author":"HM Sowter","year":"2001","unstructured":"Sowter HM, Ratcliffe PJ, Watson P, et al. HIF-1-dependent regulation of hypoxic induction of the cell death factors BNIP3 and NIX in human tumors. Can Res. 2001;61(18):6669\u201373.","journal-title":"Can Res"},{"key":"2840_CR52","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.923890","volume":"12","author":"Y Zhu","year":"2022","unstructured":"Zhu Y, Chen B, Yan J, et al. BNIP3 upregulation characterizes cancer cell subpopulation with increased fitness and proliferation. Front Oncol. 2022;12: 923890. https:\/\/doi.org\/10.3389\/fonc.2022.923890.","journal-title":"Front Oncol"},{"issue":"11","key":"2840_CR53","doi-asserted-by":"publisher","first-page":"3390","DOI":"10.3390\/cancers12113390","volume":"12","author":"AS Gorbunova","year":"2020","unstructured":"Gorbunova AS, Yapryntseva MA, Denisenko TV, et al. BNIP3 in lung cancer: To kill or rescue? Cancers. 2020;12(11):3390. https:\/\/doi.org\/10.3390\/cancers12113390.","journal-title":"Cancers"},{"issue":"1","key":"2840_CR54","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1002\/(SICI)1521-1878(199901)21:1<61::AID-BIES8>3.0.CO;2-H","volume":"21","author":"DS Salomon","year":"1999","unstructured":"Salomon DS, Bianco C, De Santis M. Cripto: a novel epidermal growth factor (EGF)-related peptide in mammary gland development and neoplasia. BioEssays News Rev Mol Cell Dev Biol. 1999;21(1):61\u201370. https:\/\/doi.org\/10.1002\/(SICI)1521-1878(199901)21:1%3c61::AID-BIES8%3e3.0.CO;2-H.","journal-title":"BioEssays News Rev Mol Cell Dev Biol"},{"issue":"2","key":"2840_CR55","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1002\/jcp.20062","volume":"201","author":"L Strizzi","year":"2004","unstructured":"Strizzi L, Bianco C, Normanno N, et al. Epithelial mesenchymal transition is a characteristic of hyperplasias and tumors in mammary gland from MMTV-Cripto-1 transgenic mice. J Cell Physiol. 2004;201(2):266\u201376. https:\/\/doi.org\/10.1002\/jcp.20062.","journal-title":"J Cell Physiol"},{"issue":"1","key":"2840_CR56","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1006\/excr.2000.4881","volume":"257","author":"AD Ebert","year":"2000","unstructured":"Ebert AD, Wechselberger C, Nees M, et al. Cripto-1-induced increase in vimentin expression is associated with enhanced migration of human Caski cervical carcinoma cells. Exp Cell Res. 2000;257(1):223\u20139. https:\/\/doi.org\/10.1006\/excr.2000.4881.","journal-title":"Exp Cell Res"},{"issue":"10","key":"2840_CR57","doi-asserted-by":"publisher","first-page":"912","DOI":"10.1002\/bies.1132","volume":"23","author":"P Savagner","year":"2001","unstructured":"Savagner P. Leaving the neighborhood: molecular mechanisms involved during epithelial-mesenchymal transition. BioEssays News Rev Mol Cell Dev Biol. 2001;23(10):912\u201323. https:\/\/doi.org\/10.1002\/bies.1132.","journal-title":"BioEssays News Rev Mol Cell Dev Biol"},{"issue":"24","key":"2840_CR58","doi-asserted-by":"publisher","first-page":"11495","DOI":"10.1073\/pnas.88.24.11495","volume":"88","author":"J Behrens","year":"1991","unstructured":"Behrens J, L\u00f6wrick O, Klein-Hitpass L, et al. The E-cadherin promoter: functional analysis of a G.C-rich region and an epithelial cell-specific palindromic regulatory element. Proc Natl Acad Sci USA. 1991;88(24):11495\u20139. https:\/\/doi.org\/10.1073\/pnas.88.24.11495.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"8","key":"2840_CR59","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1016\/s0006-2952(00)00427-5","volume":"60","author":"B Boyer","year":"2000","unstructured":"Boyer B, Vall\u00e9s AM, Edme N. Induction and regulation of epithelial-mesenchymal transitions. Biochem Pharmacol. 2000;60(8):1091\u20139. https:\/\/doi.org\/10.1016\/s0006-2952(00)00427-5.","journal-title":"Biochem Pharmacol"},{"issue":"4","key":"2840_CR60","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1016\/j.cell.2008.03.027","volume":"133","author":"SA Mani","year":"2008","unstructured":"Mani SA, Guo W, Liao MJ, et al. The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell. 2008;133(4):704\u201315. https:\/\/doi.org\/10.1016\/j.cell.2008.03.027.","journal-title":"Cell"},{"issue":"8","key":"2840_CR61","doi-asserted-by":"publisher","first-page":"7405","DOI":"10.18632\/aging.205766","volume":"16","author":"R Zhao","year":"2024","unstructured":"Zhao R, Lu Y, Wan Z, et al. Identification and validation of an anoikis-related genes signature for prognostic implication in papillary thyroid cancer. Aging. 2024;16(8):7405\u201325. https:\/\/doi.org\/10.18632\/aging.205766.","journal-title":"Aging"}],"container-title":["Discover Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-025-02840-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12672-025-02840-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-025-02840-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,10]],"date-time":"2025-06-10T18:57:47Z","timestamp":1749581867000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12672-025-02840-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,10]]},"references-count":61,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2840"],"URL":"https:\/\/doi.org\/10.1007\/s12672-025-02840-5","relation":{},"ISSN":["2730-6011"],"issn-type":[{"value":"2730-6011","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,10]]},"assertion":[{"value":"16 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 June 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Patient consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1051"}}